-+ 0.00%
-+ 0.00%
-+ 0.00%

RECURSION ANNOUNCES $200 MILLION OVERSUBSCRIBED FOLLOW-ON OFFERING, CLINICAL DATA UPDATES, AND PARTNERSHIP MILESTONE

Reuters·10/15/2026 12:22:20

Please log in to view news